Nikolai from Norway

Registered at the short selling broker Skilling, 5 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Tilray, Inc. (TLRY) stock information

Tilray, Inc.

24h Change

6.32 %


Live rate: Market closed

Stock data per Friday 22 May, 2020

0.61 (+ 6.32%)
US Market is closed

Live Stock price in graph for Tilray, Inc. (TLRY)

Data updated continously for TLRY, showing up to the 500 most recent 100 data points

  • Latest Volume

    43,098,674 (53.79 %)

  • Volume prev. day


  • Avg. daily volume


  • Market cap


  • P/E ratio


  • Today high


  • Today low


  • 52 week high


  • 52 week low


  • YTD Change



Latest news about Tilray, Inc.

Below you can find the most recent news posts about Tilray, Inc., primarily from US and UK based news sources.

Cannabis Stock Gainers And Losers From May 21, 2020

Friday, 22 May 2020, 00:47:08
Gainers Axim Biotechnologies (OTC: AXIM ) shares closed up 114% at $0.31 Harvest One Cannabis (OTC: HRVOF ) shares closed up 68.72% at $0.10 Helix TCS (OTC: HLIX ) shares closed up 46.89% at $0.26 Aurora Cannabis (NYSE: ACB ) shares closed up 34.67% at $17.17 Canopy Rivers (OTC: CNPOF ) shares closed up 24.91% at $0.85 SOL Global Investments (OTC: SOLCF ) shares closed up 30.46% at $0.34 Intec Pharma (NASDAQ: NTEC ) shares closed up 22.92% at $0.30 Tilray (NASDAQ: TLRY ) shares closed … Full story available on
— Benzinga Feeds

How Safe, Legal Pot Boosted Tilray Stock in COVID-19 Era

Wednesday, 20 May 2020, 12:00:06
No summary available.
— 24/7 Wall street

What Do Analysts Think about Tilray after Its Q1 Results? – Market Realist

Tuesday, 19 May 2020, 15:48:15
Tilray (NASDAQ:TLRY) posted its first-quarter earnings on May 11. The revenue growth was impressive in the first quarter.
— Market Realist

The Week In Cannabis: Stocks Get Big Boost From Aurora, Banking Moves In US, Exports From Israel

Sunday, 17 May 2020, 14:00:33
In a news-heavy week, we witnessed big earnings releases, with Aurora Cannabis Inc (NYSE: ACB ) (TSE: ACB) getting the most attention. The Edmonton, Canada-based company reported a 35% sequential sales increase for the third quarter, far exceeding analyst expectations. Net revenue came in at $78.4 million, excluding provisions of $2.9 million. That’s an increase of 18% over the prior quarter. While its EBITDA loss was about $10 million worse than consensus forecasted, international medical sales and Canadian recreational sales beat estimates, and gross margins expanded to 42.2%. “This was clearly a case of the patient being presumed dead, when indeed it’s not,” Alan Brochstein, founder of 420 Investor and New Cannabis Ventures, told Benzinga. Following the release, analysts at Cantor Fitzgerald reiterated an Overweight rating and CA$22 price target, while Piper Sandler trimmed its target from CA$12 to CA$10. Brochstein expects the price to strike about CA$15. On the other hand, Tilray Inc (NASDAQ: TLRY ) announced a first-quarter year-over-year revenue increase of 126.2% to $52.1 million, beating the Street’s estimate of $50.62 million.
— Benzinga Feeds

Work briefly halted at Ontario cannabis greenhouse over COVID-19 infection

Wednesday, 13 May 2020, 19:48:40
Work was temporarily suspended at a cannabis greenhouse owned by a one of Tilray’s subsidiaries earlier this week after a worker tested positive for the COVID-19 virus. The individual, employed through a third-party agency, had been working in a cultivation facility in Leamington, Ontario run by High Park Gardens, which was acquired by Tilray last […] Work briefly halted at Ontario cannabis greenhouse over COVID-19 infection is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
— Marijuana Business Daily